Combination Therapy of Ursodeoxycholic Acid and Corticosteroids for Primary Biliary Cirrhosis with Features of Autoimmune Hepatitis: A Meta-Analysis

被引：19

作者：

Zhang, Yan ^{[1
]}

Lu, Jie ^{[1
]}

Dai, Weiqi ^{[1
]}

Wang, Fan ^{[1
]}

Shen, Miao ^{[1
]}

Yang, Jing ^{[1
]}

Zhu, Rong ^{[1
]}

Zhang, Huawei ^{[1
]}

Chen, Kan ^{[1
]}

Cheng, Ping ^{[1
]}

He, Lei ^{[1
]}

Wang, Chengfen ^{[1
]}

Xu, Ling ^{[1
]}

Zhou, Yingqun ^{[1
]}

Guo, Chuanyong ^{[1
]}

机构：

[1] Tongji Univ, Sch Med, Dept Gastroenterol, Shanghai Peoples Hosp 10, Shanghai 200072, Peoples R China

来源：

GASTROENTEROLOGY RESEARCH AND PRACTICE | 2013年 / 2013卷

基金：

中国国家自然科学基金;

关键词：

OVERLAP SYNDROME; QUALITY; BUDESONIDE; TRIALS;

D O I：

10.1155/2013/490731

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

A meta-analysis was performed of RCTs comparing therapies that combine UDCA and corticosteroids with UDCA monotherapy. In this paper, we found that the combination therapy of UDCA and corticosteroids was more effective for PBC-AIH.

引用

页数：9

共 50 条

[31] Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome:: features and response to therapy
Poupon, R
Chazouillères, O
Poupon, RE
BILE ACIDS AND CHOLESTASIS, 1999, 108 : 247 - 253
[32] Clinical profile of primary biliary cirrhosis with features of autoimmune hepatitis: Importance of corticosteroid therapy
Yoshioka, Youko
Taniai, Makiko
Hashimoto, Etsuko
Haruta, Ikuko
Shiratori, Keiko
HEPATOLOGY RESEARCH, 2014, 44 (09) : 947 - 955
[33] Primary biliary cirrhosis autoimmune hepatitis overlap syndrome:: Clinical features and response to therapy
Chazouillères, O
Wendum, D
Serfaty, L
Montembault, S
Rosmorduc, O
Poupon, R
HEPATOLOGY, 1998, 28 (02) : 296 - 301
[34] The efficacy of ursodeoxycholic acid and bezafibrate combination therapy for primary biliary cirrhosis: A prospective, multicenter study
Iwasaki, Shinji
Ohira, Hiromasa
Nishiguchi, Shuhei
Zeniya, Mikio
Kaneko, Shuichi
Onji, Morikazu
Ishibashi, Hiromi
Sakaida, Isao
Kuriyama, Shigeki
Ichida, Takafumi
Onishi, Saburo
Toda, Gotaro
HEPATOLOGY RESEARCH, 2008, 38 (06) : 557 - 564
[35] PROGNOSIS OF PRIMARY BILIARY CIRRHOSIS WITH FEATURES OF AUTOIMMUNE HEPATITIS OVERLAP SYNDROME. ROLE OF URSODEOXYCHOLIC ACID IN LONG-TERM SURVIVAL
Pares, A.
JOURNAL OF HEPATOLOGY, 2013, 58 : S391 - S391
[36] Features, prognosis and management of primary biliary cirrhosis in the era of ursodeoxycholic acid
Poupon, R.
Chazouilleres, O.
Chretien, Y.
Corpechot, C.
BILE ACID BIOLOGY AND THERAPEUTIC ACTIONS, 2009, 165 : 277 - 285
[37] Good long-term survival of patients with primary biliary cirrhosis and biochemical features of autoimmune hepatitis overlap syndrome. Influence of ursodeoxycholic acid therapy
Pares, Albert
HEPATOLOGY, 2012, 56 : 1138A - 1139A
[38] Effect of ursodeoxycholic acid on cholestatic features and complications of primary biliary cirrhosis
Jazrawi, RP
Verma, A
Ahmed, HA
Northfield, TC
BILE ACIDS AND CHOLESTASIS, 1999, 108 : 231 - 246
[39] IMPACT OF COMBINATION THERAPY WITH URSODEOXYCHOLIC ACID AND BEZAFIBRATE ON PATIENT OUTCOMES IN PRIMARY BILIARY CHOLANGITIS: A META-ANALYSIS OF RANDOMIZED CONTROLLED TRIALS
Khakoo, Nidah S.
Sultan, Shahnaz
Serna, Myrna K.
Bhamidimarri, Kalyan R.
Levy, Cynthia
GASTROENTEROLOGY, 2020, 158 (06) : S1374 - S1375
[40] Autoimmune conditions associated with primary biliary cirrhosis: Prevalence, natural history and response to ursodeoxycholic acid therapy
Zukowski, TH
Jorgensen, RA
Lindor, KD
GASTROENTEROLOGY, 1997, 112 (04) : A1425 - A1425

← 1 2 3 4 5 →